US - HealthQuill

A child’s brain gets excessively or abnormally active when they are not treated for anxiety disorders, according to a study by the US National Institutes of Health.

CBT treatment may aid anxiety disorders in children: NIH study

HQ Team February 3, 2024: A child’s brain gets excessively or abnormally active when they are not treated for anxiety disorders, according to.

by HealthQuill
February 4, 2024
0 Comments

The UN Secretary-General António Guterres met with 35 donor nations and appealed for the restoration of funds to a UN body working for Palestine refugees that is being accused by Israel of participation in the October 7 attacks.

Drugs Health Pharma

Palestine refugees’ fate hangs in balance as UN chief meets donor nations

The UN Secretary-General António Guterres met with 35 donor nations and appealed for the restoration of funds to a UN body working for.

by HealthQuill
January 31, 2024
0 Comments

The national public health agency of the US has issued a nationwide alert to healthcare providers to track measles, following a concern for a potential rise in imported cases associated with increased international travel in summer.

Drugs Health Pharma

CDC issues alert on measles in US as cases rise due to global travel

HQ Team January 27, 2024: The national public health agency of the US has issued a nationwide alert to healthcare providers to track.

by HealthQuill
January 27, 2024
0 Comments

British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes medicines to treat asthma.

Drugs Health Pharma

GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion

HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company Aiolos Bio Inc., which makes.

by HealthQuill
January 9, 2024
0 Comments

About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave of the Covid-19 pandemic, according to a study.

Drugs Health Pharma

Antimalarial drug may have killed 17,000 people in first Covid-19 wave

HQ Team January 8, 2024: About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave.

by HealthQuill
January 8, 2024
0 Comments

The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.

Drugs Health Pharma

JN.1 sub-variant Covid-19 cases rise to 62% in the US, says CDC

HQ Team January 8, 2023: The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared.

by HealthQuill
January 8, 2024
0 Comments

More than 50 million people in the US experience an allergic reaction every year. They are the sixth leading cause of long-term illness in that country. In India allergies are a growing concern and about 20-30% of the population suffer from at least one allergic disease.

Drugs Health Pharma

Opinion: Curb calls, use earbuds, dump old mobile phones to fight allergens

By Dr K. Leelamoni January 3, 2024: I started fretting a month ago when my friend Radhika stopped answering my cellphone calls. She.

by HealthQuill
January 3, 2024
1 Comment

Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to treat nervous system impairment.

Drugs Health Pharma

USFDA clears AstraZeneca-Ionis’ drug for nervous system impairment

HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.